StockSelector.com
  Research, Select, & Monitor Wednesday, April 26, 2017 1:44:53 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
United Therapeutics Corp.$118.56($3.18)(2.61%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

United Therapeutics Corp. has an overall rank of 600 out of 6950 stocks based on 11 positive rankings and 9 negative rankings.

Positive Rankings
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, United Therapeutics is ranked 3.
Oversold RSI
The 14 Day Relative-Strength Index for United Therapeutics is 27.0. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, United Therapeutics is ranked 48.
Highest ROA
United Therapeutics rank is 60
Highest Cash Growth
United Therapeutics rank is 128
Highest Net Margin
United Therapeutics rank is 152
Highest ROE
United Therapeutics rank is 203
Historic EPS Growth
United Therapeutics rank is 218
Top Industry Values
United Therapeutics rank is 246
Debt-to-Equity
United Therapeutics rank is 546
Low Put/Call
United Therapeutics has a low Put/Call ratio of 0.25 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, United Therapeutics is ranked 629.
Historic Revenue Growth
United Therapeutics rank is 770
Negative Rankings
Negative EPS Growth
United Therapeutics rank is 48
Negative Revenue Estimate
United Therapeutics rank is 144
Missed Whisper
According to EarningsWhispers.com, United Therapeutics missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Down EPS Surprise
United Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
High vPut/Call
United Therapeutics has a high Put/Call ratio of 1.62 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, United Therapeutics is ranked 840.
90 Day Loss
United Therapeutics rank is 894
10 Day Loss
United Therapeutics rank is 1394
Price-to-Book
United Therapeutics rank is 1707
Price-to-Sales
United Therapeutics rank is 1752







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.